Lúcio Lara Santos
University of Porto
CancerPathologyOncologyAntigenImmunologyImmunohistochemistryUrotheliumCarcinomaImmunotherapyMetastasisDiseaseBladder cancerProteomicsCancer researchCarcinogenesisCell growthMedicineUrinary systemBiologyCancer cell
185Publications
29H-index
2,900Citations
Publications 183
Newest
#1Cristina P.R. Xavier (University of Porto)H-Index: 12
#2Inês Castro (University of Porto)H-Index: 2
Last. M. Helena Vasconcelos (University of Porto)H-Index: 31
view all 9 authors...
Abstract Tumour-associated macrophages have been implicated in pancreatic ductal adenocarcinoma (PDAC) therapy response and Extracellular vesicles (EVs) shed by macrophages might have a role in this process. Here, we demonstrated that large EVs released by anti-inflammatory human macrophages decreased PDAC cellular sensitivity to gemcitabine. Using proteomic analysis, chitinase 3-like-1 (CHI3L1) and fibronectin (FN1) were identified as two of the most abundant proteins in the cargo of macrophage...
2 CitationsSource
Source
Pancreatic ductal adenocarcinoma (PDAC) is considered one of the deadliest tumors worldwide. The diagnosis is often possible only in the latter stages of the disease, with patients already presenting an advanced or metastatic tumor. It is also one of the cancers with poorest prognosis, presenting a five-year survival rate of around 5%. Treatment of PDAC is still a major challenge, with cytotoxic chemotherapy remaining the basis of systemic therapy. However, no major advances have been made recen...
Source
#1Carlos SelemaneH-Index: 1
#2Luisa JamisseH-Index: 1
Last. Lúcio Lara SantosH-Index: 29
view all 12 authors...
Source
Understanding the individualized risks of undertaking surgical procedures is essential to personalize preparatory, intervention and post-care protocols for minimizing post-surgical complications. This knowledge is key in oncology given the nature of interventions, the fragile profile of patients with comorbidities and cytotoxic drug exposure, and the possible cancer recurrence. Despite its relevance, the discovery of discriminative patterns of post-surgical risk is hampered by major challenges: ...
Source
#1Ana PeixotoH-Index: 20
Last. José Alexandre FerreiraH-Index: 21
view all 15 authors...
Bladder cancer constitutes one of the deadliest genitourinary diseases, especially when diagnosed at late stages. These tumours harbour microenvironmental niches characterized by low levels of oxygen (hypoxia) and limited glucose supply due to poor vascularization. However, the synergic contribution of these features to disease development is poorly understood. Here, we demonstrated that cells with distinct histopathological and molecular backgrounds responded similarly to such stimuli. Cancer c...
Source
Esophageal cancer (EC) is a life-threatening disease, demanding the discovery of new biomarkers and molecular targets for precision oncology. Aberrantly glycosylated proteins hold tremendous potential towards this objective. In the current study, a series of esophageal squamous cell carcinomas (ESCC) and EC-derived circulating tumor cells (CTCs) were screened by immunoassays for the sialyl-Tn (STn) antigen, a glycan rarely expressed in healthy tissues and widely observed in aggressive gastrointe...
Source
Source
#1Lúcio Lara SantosH-Index: 29
#2Júlio SantosH-Index: 5
Last. José Manuel Correia da Costa (University of Porto)H-Index: 22
view all 8 authors...
Schistosomiasis is the most important helminthiasis worldwide in terms of morbidity and mortality. Most of the infections occurs in Africa, which about two thirds are caused by Schistosoma haematobium. The infection with S. haematobium is considered carcinogenic leading to squamous cell carcinoma (SCC) and urothelial carcinoma of the urinary bladder. Additionally, it is responsible for female genital schistosomiasis leading to infertility and higher risk of human immunodeficiency virus (HIV) tra...
1 CitationsSource
12345678910
Close Researchers